Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Won Kyung Hur"'
Autor:
Leeseul Kim, Yoonhee Choi, Chan Mi Jung, Won Kyung Hur, Lesli A. Kiedrowski, Jaeyoun Choi, William H. Bae, Young Kwang Chae, Myungwoo Nam, Heayoon S. Cho, Christmann Low, Jin Young Hwang, Stanislav Fridland, Elena Vagia, Emma Yu, Eugene Kim
Publikováno v:
JCO Precision Oncology. :751-755
Autor:
William Han, Bae, Jin Young, Hwang, Won Kyung, Hur, Jaeyoun, Choi, Myungwoo, Nam, Yoonhee, Choi, Leeseul, Kim, Eugene, Kim, Stanislav, Fridland, Heayoon Shauna, Cho, Christmann, Low, Emma, Yu, Chan Mi, Jung, Elena, Vagia, Lesli, Kiedrowski, Young Kwang, Chae
Publikováno v:
JCO precision oncology. 5
Autor:
Myungwoo Nam, William Han Bae, Young Kwang Chae, Won Kyung Hur, Jin Young Hwang, Emma Yu, Chan Mi Jung, William Cheng, Eugene Kim, Leeseul Kim, Yeun Ho Lee, Yoonhee Choi
Publikováno v:
Cancer Research. 81:673-673
The role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes in cancer patients treated with immune checkpoint inhibitors(ICI)Background Although immune checkpoint inhibitors (ICI) have changed the therapeutic schem
Autor:
Christmann Low, William Cheng, Emma Yu, Young Kwang Chae, Eugene Kim, Yoonhee Choi, Cyra Y. Kang, Chan Mi Jung, Jin Young Hwang, William H. Bae, Myungwoo Nam, Heayoon Shauna Cho, Yeun Ho Lee, Won Kyung Hur, Leeseul Kim
Publikováno v:
Cancer Research. 81:678-678
Background: Immune checkpoint inhibitor (ICI) treatment became the new treatment paradigm of a wide spectrum of cancers in the last decade. However, overcoming unresponsiveness to ICI remains an important high unmet need in the field of immuno-oncolo
Autor:
William Cheng, William Han Bae, Myungwoo Nam, Eugene Kim, Christmann Low, Yoonhee Choi, Chan Mi Jung, Jeff Chuang, Jin Young Hwang, Emma Yu, Yeun Ho Lee, Young Kwang Chae, Heayoon S. Cho, Victor Wang, Won Kyung Hur, Leeseul Kim
Publikováno v:
Cancer Research. 81:626-626
Background: Apart from its role in ovarian cancer progression, epithelial-mesenchymal transition (EMT) can promote chemotherapy resistance. We aimed to analyze how the EMT score would affect the tumor microenvironment in ovarian cancer. Methods: cBio
Autor:
Chan Mi Jung, Yoonhee Choi, William Cheng, Jeff Chuang, Leeseul Kim, Young Kwang Chae, William H. Bae, Eugene Kim, Won Kyung Hur, Myungwoo Nam, Heayoon S. Cho, Victor Wang, Jin Young Hwang, Yeun Ho Lee, Emma Yu
Publikováno v:
Cancer Research. 81:451-451
We aimed to understand how TGF-β signaling pathway related gene mutation affects the tumor neoantigen burden and immune landscape in uterine corpus endometrial carcinoma (UCEC). cBioPortal was queried to obtain the UCEC The Cancer Genome Atlas (TCGA
Autor:
Chan Mi Jung, Victor Wang, Yoonhee Choi, Myungwoo Nam, William Cheng, William H. Bae, Christmann Low, Won Kyung Hur, Young Kwang Chae, Jin Young Hwang, Jeff Chuang, Yeun Ho Lee, Leeseul Kim, Heayoon S. Cho, Emma Yu, Eugene Kim
Publikováno v:
Cancer Research. 81:453-453
Background: Within serous ovarian cancer (SOC), high-grade serous carcinoma (HGSC) demonstrates a worse prognosis compared to low-grade serous carcinoma (LGSC). Molecular analysis of SOC has revealed a distinct pattern of mutations found between the
Autor:
Won Kyung Hur, Chan Mi Jung, Emma Yu, Elena Vagia, Jin Young Hwang, Young Kwang Chae, Christmann Low, Heayoon S. Cho, William Cheng, Eugene Kim, Myungwoo Nam, William Han Bae, Leeseul Kim, Yoonhee Choi, Yeun Ho Lee
Publikováno v:
Cancer Research. 81:519-519
Hyperprogression is a severe adverse event usually reported in immunogenic cancers such as non-small cell lung cancer (NSCLC) and melanoma after immunotherapy. Currently, there are no reported cases of hyperprogression seen in thyroid cancer. Here, w
Autor:
William Cheng, Victor Wang, Young Kwang Chae, Jin Young Hwang, Yoonhee Choi, Yeun Ho Lee, Myungwoo Nam, William H. Bae, Jeff Chuang, Won Kyung Hur, Eugene Kim, Leeseul Kim, Chan Mi Jung, Emma Yu
Publikováno v:
Cancer Research. 81:452-452
TP53-mutation is a poor prognostic marker for uterine corpus endometrial carcinoma (UCEC). TGF-β is known to promote tumor progression via immune suppression, particularly NK and T cell-mediated cytotoxicity, in the tumor microenvironment. We aimed
Autor:
William Han Bae, Won Kyung Hur, Chan Mi Jung, William Cheng, Jin Young Hwang, Leeseul Kim, Yeun Ho Lee, Young Kwang Chae, Yoonhee Choi, Heayoon S. Cho, Myungwoo Nam
Publikováno v:
Cancer Research. 81:520-520
Early recognition of immune-related adverse events (irAEs) of immunotherapy is important. Circulating proteome reflects host response to diseases and is being explored as a marker for response to immunotherapy. We used a serum-based proteomics test,